Skip to content

Impact of Clinical Guidance & Point-of-care CRP in Children: the ARON Project

Impact of a Diagnostic Algorithm on Antibiotic Prescribing Rate and Further Management of Acutely Ill Children Presenting to Ambulatory Care: Multicentre, Cluster-randomized, Parallel Group Pragmatic Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04470518
Acronym
ARON
Enrollment
6750
Registered
2020-07-14
Start date
2021-01-06
Completion date
2024-04-24
Last updated
2025-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

antibiotic prescription, infections, decision tree, point-of-care C-reactive protein test, safetynet advice

Brief summary

Impact of clinical guidance & point-of-care CRP test in children: the ARON project Trial Design: multicentre, cluster-randomized, parallel group pragmatic trial Trial Participants and setting: Children aged 6 months to 12 years of age with an acute illness episode presenting to in-hours general practice or out-of-hospital community paediatrics offices Intervention(s) Diagnostic algorithm: 1. Clinical decision tree: clinician's gut feeling something is wrong, dyspnea, temperature ≥40ºC 2. YES to any : point-of-care CRP ≥5mg/L: additional testing or refer to secondary care \<5mg/L: safety netting\*, only prescribe antibiotics if advised (guidelines) 3. NO to all : are AB considered? YES : point-of-care CRP ≥5mg/L: safety netting\*, only prescribe antibiotics if advised (guidelines) \<5mg/L: safety netting\*, do not prescribe antibiotics NO: safety netting \*safety netting advice: * inform parents on what to expect and what to look out for * interactive parent information booklet based on previous research Control: Diagnosis and Treatment/Management as per usual care: \- guidance on AB prescribing: o Belgische Commissie voor de Coördinatie van het Antibioticabeleid (BAPCOC) guide (updated November 2019) o RIZIV consensus meeting report Antibiotics in children in ambulatory care Primary Endpoint: Antibiotic prescribing rate at index consultation Secondary Endpoint(s) \- time until full clinical recovery (during follow up (day 1 to day 30)) \- additional investigations (at index consultation and/or during follow up (day 1 to day 30)) \- re-consultation (during follow up (day 1 to day 30)) \- antibiotic prescribing rate (during follow up (day 1 to day 30)) Exploratory endpoints at the index consultation: * additional investigations (X-Ray, blood tests, urine tests, etc.) During a follow-up period (day 1 to day 30): \- referral to hospital \- additional investigations (X-Ray, blood tests, urine tests, etc.) * patients with full clinical recovery at day 7 and day 30 * admission to hospital * mortality * cost-effectiveness * patient satisfaction * qualitative study: endpoints Planned Sample Size: 7000 Timing of the intervention: Intervention at index consultation (at presentation to primary care) Follow-up duration: 30 days follow-up Duration of the trial (FPI-CSR): 43 months

Detailed description

The investigators aim to strengthen the assessment of acutely ill children in primary care, by introducing a diagnostic algorithm that can decrease antibiotic prescribing. In light of the prior evidence and its results so far, the ARON trial will test the impact of a diagnostic algorithm including a standardised clinical assessment, a POC CRP test, and safety netting advice. Therefore, the investigators propose to assess the clinical and cost-effectiveness of a diagnostic algorithm which includes a decision tree, POC CRP and safety netting advice in acutely ill children aged 6 months to 12 years of age presenting to ambulatory care, on AB prescribing, referral/admission to hospital, additional testing, mortality, and patient satisfaction. More specifically, the investigators' research question is whether this diagnostic algorithm is able to safely reduce antibiotic prescribing in acutely ill children presenting to ambulatory care. The decision whether or not to conduct a POC CRP test will depend on the standardized clinical assessment, i.e. a validated clinical decision tree, and subsequently for low-risk children on the intention to prescribe AB. The investigators will provide clear evidence-based guidance on how to interpret the CRP test result as outlined below. A process evaluation will examine how clinicians use CRP testing in their practice and how parents experience these consultations. The investigators propose a study, where children (6 months to 12 years of age) will be randomised to (a) a diagnostic algorithm with CRP testing and specific guidance on when to prescribe AB or (b) usual care. CRP testing will be done using a finger prick test (result within 4 minutes). The CRP level will then be given to the clinician who will communicate the result to the child/parents. The investigators aim to recruit 7000 children and will collect data registered by the participating physician, from the child's health record and children/parents directly. The investigators will describe how the intervention has worked in practice and how clinicians/parents have experienced these consultations. Guidance will be part of a diagnostic algorithm which includes clinically guided POC CRP testing and safety netting advice to inform parents on what to expect and what to look out for. Individual interviews will be conducted with clinicians and parents taking part in the trial within 30 days after the first contact consultation, to explore the social processes influencing embedding of the intervention within practice, and behaviour change techniques. These individual telephone interviews will be performed with a selection of parents to address whether their concerns were discussed appropriately and whether their expectations were met and how they experienced the consultation and/or POC CRP testing. The safety-netting advice will be supported by a parent information booklet, based on previous research (the When should I worry-interactive booklet (a guide to Coughs, Colds, Earache & Sore Throats), the Mijn kind heeft koorts booklet (Eefje de Bont, www.thuisarts.nl), and the Caring for children with coughs-leaflet (information about how to look after a child who has a cough and when to see the doctor)). The findings of this study could change the practice of ambulatory care physicians and might be of great interest to parents and childcare providers. The investigators will publish the findings of this research in academic journals, present at national conferences and discuss results with groups responsible for the national guidance on how to assess acutely ill children (Domus Medica, SSMG).

Interventions

Guidance will be part of a diagnostic algorithm which includes clinically guided point-of-care C-reactive protein testing and safety netting advice to inform parents on what to expect and what to look out for. A selection of clinical features will be assessed and recorded by the physician in the patient's health record and on the e-CRF, including the clinical decision tree (clinician's gut feeling, body temperature, dyspnea). The safety-netting advice will be supported by a parent information booklet, based on previous research (the When should I worry-interactive booklet (a guide to Coughs, Colds, Earache & Sore Throats), the Mijn kind heeft koorts booklet (Eefje de Bont, www.thuisarts.nl), and the Caring for children with coughs-leaflet (information about how to look after a child who has a cough and when to see the doctor)).

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
University Ghent
CollaboratorOTHER
Universiteit Antwerpen
CollaboratorOTHER
University of Liege
CollaboratorOTHER
Vrije Universiteit Brussel
CollaboratorOTHER
Université Catholique de Louvain
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

Owing to study procedures, children, their parents and physicians will not be masked to the practices' random allocation.

Intervention model description

multicentre, cluster-randomized, parallel group pragmatic trial

Eligibility

Sex/Gender
ALL
Age
6 Months to 12 Years
Healthy volunteers
No

Inclusion criteria

for practices: * Being able to recruit acutely ill children (ideally consecutively) * Agree to the terms of the clinical study agreement.

Exclusion criteria

for practices: * Currently using a POC CRP device as part of their routine care * No practices will be excluded on other grounds than the above. Age, demographics, geographic region will not be used to exclude eligible practices. This will provide us with a real-life, representative subset of ambulatory care physicians. Inclusion criteria for children * Children aged 6 months to 12 years, provided informed consent can be obtained * presenting with an acute illness episode that started maximum 10 days before the index consultation

Design outcomes

Primary

MeasureTime frameDescription
Antibiotic Prescribing Rate at Index Consultation (Immediate or Delayed)This outcome will be registered immediately at the index consultation (immediately after the intervention)The primary outcome is the percentage of participants who were prescribed antibiotic treatment (both immediate and delayed) at the index consultation as recorded by the treating physician.

Secondary

MeasureTime frameDescription
Clinical Recovery During Follow-upThis outcome will be checked from the diary (via app for parents) from first day after the intervention until day of full clinical recovery (up to maximum 30 days after after the intervention)the duration (in days) until reaching full clinical recovery
Additional Investigations at Index Consultation and/or During Follow-upThis composite outcome will be registered immediately after the intervention and/or checked from the patient health record from the first day to day 30 after the interventionthe percentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) at index consultation (day 0) and/or during follow-up (day 1 to day 30)
Re-consultation During Follow-upThis outcome will be checked from the patient health record from first day to day 30 after the interventionpercentage of subjects who re-consulted their physician during follow-up (day 1 to day 30)
Antibiotic Prescribing Rate During Follow-upThis outcome will be checked from the patient health record first day to day 30 after the interventionpercentage of subjects who were prescribed antibiotic treatment during follow-up (day 1 to day 30)

Other

MeasureTime frameDescription
Admission to Hospital During Follow-upduring follow-up from first day to day 30 after the interventionpercentage of subjects admitted to hospital during follow-up (day 1 to day 30)
Mortality at Day 0This outcome will be registered immediately at the index consultationpercentage of subjects who died at index consultation (day 0)
Mortality During Follow upduring follow-up from first day to day 30 after the interventionpercentage of subjects who died during follow-up (day 1 to day 30)
Clinical Recovery at Day 7at day 7 after the interventionpercentage of subjects with full clinical recovery at day 7
Clinical Recovery at Day 30at day 30 after the interventionpercentage of subjects with full clinical recovery at day 30
Additional Testing at Index ConsultationThis outcome will be registered immediately at the index consultationpercentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) at index consultation (day 0)
Parent's Experience Through Semi-structured Interviewswithin 7 days after the interventionParent's experience through semi-structured interviews with pre-defined topic guide
Physician's Experience Through Semi-structured Interviewswithin 7 days after the interventionPhysician's experience through semi-structured interviews with pre-defined topic guide
Cost-effectiveness of the Interventionwill be assessed retrospectively after data collection has finished (24 months of recruitment)Cost-effectiveness of the intervention: healthcare expenditures in terms of hospitalization, consultations, pharmaceuticals (reimbursed and non-reimbursed), productivity, quality of life
Number of Participants Whose Physician Was Non-Adherent to the Diagnostic AlgorithmThis outcome will be registered immediately at the index consultationclinicians could deviate from the proposed diagnostic algorithm. This outcome measure comprise the percentage of participants whose physician was non-adherent to the diagnostic algorithm. This is not a protocol violation, since deviating from the algorithm was a possibility if the physician deems this necessary.
Patient's Experience Through Semi-structured Interviewswithin 7 days after the interventionPatient's experience through semi-structured interviews with pre-defined topic guide
Additional Testing During Follow-upduring follow-up from first day to day 30 after the interventionpercentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) during follow-up (day 1 to day 30)
Referral to Hospital at Day 0This outcome will be registered immediately at the index consultationpercentage of subjects referred to hospital at index consultation (day 0)
Referral to Hospital During Follow-upduring follow-up from first day to day 30 after the interventionpercentage of subjects referred to hospital during follow-up (day 1 to day 30)
Admission to Hospital at Day 0This outcome will be registered immediately at the index consultationpercentage of subjects admitted to hospital at index consultation (day 0)

Countries

Belgium

Participant flow

Participants by arm

ArmCount
Intervention: Diagnostic Algorithm
diagnostic algorithm including a standardised clinical assessment, a Point-of-care C-reactive protein test, and safety netting advice diagnostic algorithm: Guidance will be part of a diagnostic algorithm which includes clinically guided point-of-care C-reactive protein testing and safety netting advice to inform parents on what to expect and what to look out for. A selection of clinical features will be assessed and recorded by the physician in the patient's health record and on the e-CRF, including the clinical decision tree (clinician's gut feeling, body temperature, dyspnea). The safety-netting advice will be supported by a parent information booklet, based on previous research (the When should I worry-interactive booklet (a guide to Coughs, Colds, Earache & Sore Throats), the Mijn kind heeft koorts booklet (Eefje de Bont, www.thuisarts.nl), and the Caring for children with coughs-leaflet (information about how to look after a child who has a cough and when to see the doctor)).
2,988
Usual Care
In the control arm, patients will receive 'usual care' left at the discretion of the treating physician. Apart from the general training session for all participating physicians they have attended prior to recruitment and randomization, physicians in the control arm will not receive additional tools. They are expected (but not forced) to follow the Belgian guidelines (as described in BAPCOC National guidelines and the RIZIV consensus meeting Rational use of antibiotics in children).
3,762
Total6,750

Baseline characteristics

CharacteristicUsual CareTotalIntervention: Diagnostic Algorithm
Age, Continuous3.9 years3.75 years3.7 years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Belgium
3762 participants6750 participants2988 participants
Sex/Gender, Customized
boy
1881 Participants3447 Participants1566 Participants
Sex/Gender, Customized
girl
1881 Participants3302 Participants1421 Participants
Sex/Gender, Customized
prefer not to say
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2,9880 / 3,762
other
Total, other adverse events
32 / 2,98864 / 3,762
serious
Total, serious adverse events
0 / 2,9880 / 3,762

Outcome results

Primary

Antibiotic Prescribing Rate at Index Consultation (Immediate or Delayed)

The primary outcome is the percentage of participants who were prescribed antibiotic treatment (both immediate and delayed) at the index consultation as recorded by the treating physician.

Time frame: This outcome will be registered immediately at the index consultation (immediately after the intervention)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAntibiotic Prescribing Rate at Index Consultation (Immediate or Delayed)466 Participants
Usual CareAntibiotic Prescribing Rate at Index Consultation (Immediate or Delayed)817 Participants
Secondary

Additional Investigations at Index Consultation and/or During Follow-up

the percentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) at index consultation (day 0) and/or during follow-up (day 1 to day 30)

Time frame: This composite outcome will be registered immediately after the intervention and/or checked from the patient health record from the first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAdditional Investigations at Index Consultation and/or During Follow-up335 Participants
Usual CareAdditional Investigations at Index Consultation and/or During Follow-up517 Participants
Secondary

Antibiotic Prescribing Rate During Follow-up

percentage of subjects who were prescribed antibiotic treatment during follow-up (day 1 to day 30)

Time frame: This outcome will be checked from the patient health record first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAntibiotic Prescribing Rate During Follow-up291 Participants
Usual CareAntibiotic Prescribing Rate During Follow-up429 Participants
Secondary

Clinical Recovery During Follow-up

the duration (in days) until reaching full clinical recovery

Time frame: This outcome will be checked from the diary (via app for parents) from first day after the intervention until day of full clinical recovery (up to maximum 30 days after after the intervention)

ArmMeasureValue (MEAN)Dispersion
Intervention: Diagnostic AlgorithmClinical Recovery During Follow-up4.6 daysStandard Deviation 3.5
Usual CareClinical Recovery During Follow-up4.7 daysStandard Deviation 3.6
Secondary

Re-consultation During Follow-up

percentage of subjects who re-consulted their physician during follow-up (day 1 to day 30)

Time frame: This outcome will be checked from the patient health record from first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmRe-consultation During Follow-up770 Participants
Usual CareRe-consultation During Follow-up968 Participants
Other Pre-specified

Additional Testing at Index Consultation

percentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) at index consultation (day 0)

Time frame: This outcome will be registered immediately at the index consultation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAdditional Testing at Index Consultation249 Participants
Usual CareAdditional Testing at Index Consultation400 Participants
Other Pre-specified

Additional Testing During Follow-up

percentage of subjects receiving additional testing (including, but not limited to (X-Ray, blood tests, urine tests) during follow-up (day 1 to day 30)

Time frame: during follow-up from first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAdditional Testing During Follow-up111 Participants
Usual CareAdditional Testing During Follow-up149 Participants
Other Pre-specified

Admission to Hospital at Day 0

percentage of subjects admitted to hospital at index consultation (day 0)

Time frame: This outcome will be registered immediately at the index consultation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAdmission to Hospital at Day 07 Participants
Usual CareAdmission to Hospital at Day 011 Participants
Other Pre-specified

Admission to Hospital During Follow-up

percentage of subjects admitted to hospital during follow-up (day 1 to day 30)

Time frame: during follow-up from first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmAdmission to Hospital During Follow-up25 Participants
Usual CareAdmission to Hospital During Follow-up53 Participants
Other Pre-specified

Clinical Recovery at Day 30

percentage of subjects with full clinical recovery at day 30

Time frame: at day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmClinical Recovery at Day 302967 Participants
Usual CareClinical Recovery at Day 303747 Participants
Other Pre-specified

Clinical Recovery at Day 7

percentage of subjects with full clinical recovery at day 7

Time frame: at day 7 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmClinical Recovery at Day 72539 Participants
Usual CareClinical Recovery at Day 73200 Participants
Other Pre-specified

Cost-effectiveness of the Intervention

Cost-effectiveness of the intervention: healthcare expenditures in terms of hospitalization, consultations, pharmaceuticals (reimbursed and non-reimbursed), productivity, quality of life

Time frame: will be assessed retrospectively after data collection has finished (24 months of recruitment)

Other Pre-specified

Mortality at Day 0

percentage of subjects who died at index consultation (day 0)

Time frame: This outcome will be registered immediately at the index consultation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmMortality at Day 00 Participants
Usual CareMortality at Day 00 Participants
Other Pre-specified

Mortality During Follow up

percentage of subjects who died during follow-up (day 1 to day 30)

Time frame: during follow-up from first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmMortality During Follow up0 Participants
Usual CareMortality During Follow up0 Participants
Other Pre-specified

Number of Participants Whose Physician Was Non-Adherent to the Diagnostic Algorithm

clinicians could deviate from the proposed diagnostic algorithm. This outcome measure comprise the percentage of participants whose physician was non-adherent to the diagnostic algorithm. This is not a protocol violation, since deviating from the algorithm was a possibility if the physician deems this necessary.

Time frame: This outcome will be registered immediately at the index consultation

Population: missing data from 2 participants

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmNumber of Participants Whose Physician Was Non-Adherent to the Diagnostic Algorithm160 Participants
Other Pre-specified

Parent's Experience Through Semi-structured Interviews

Parent's experience through semi-structured interviews with pre-defined topic guide

Time frame: within 7 days after the intervention

Other Pre-specified

Patient's Experience Through Semi-structured Interviews

Patient's experience through semi-structured interviews with pre-defined topic guide

Time frame: within 7 days after the intervention

Other Pre-specified

Physician's Experience Through Semi-structured Interviews

Physician's experience through semi-structured interviews with pre-defined topic guide

Time frame: within 7 days after the intervention

Other Pre-specified

Referral to Hospital at Day 0

percentage of subjects referred to hospital at index consultation (day 0)

Time frame: This outcome will be registered immediately at the index consultation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmReferral to Hospital at Day 024 Participants
Usual CareReferral to Hospital at Day 013 Participants
Other Pre-specified

Referral to Hospital During Follow-up

percentage of subjects referred to hospital during follow-up (day 1 to day 30)

Time frame: during follow-up from first day to day 30 after the intervention

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention: Diagnostic AlgorithmReferral to Hospital During Follow-up79 Participants
Usual CareReferral to Hospital During Follow-up84 Participants

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026